You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

poly(I).poly(c12,U)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Fatigue Syndrome Trial in Incline Village, Charlotte (Poly I: Poly C12U (Rintatolimod))

Available
  • Chronic Fatigue Syndrome
  • Poly I: Poly C12U (Rintatolimod)
  • Incline Village, Nevada
  • +1 more
Apr 29, 2022

Post COVID-19 Condition, Long COVID Trial (Rintatolimod, Placebo / Normal Saline)

Not yet recruiting
  • Post COVID-19 Condition
  • Long COVID
  • (no location specified)
Oct 20, 2022

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Pancreatic Cancer Trial (Rintatolimod)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Aug 8, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,

Completed
  • HER2-positive Breast Cancer
  • +7 more
  • HER-2/neu peptide vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 4, 2020

Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

Completed
Has Results
  • Cutaneous Melanoma
  • +11 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +2 more
  • Chicago, Illinois
  • +6 more
Nov 10, 2021

Allergic Rhinitis, Asthma, Latent Tuberculosis Trial in Paddington (Poly ICLC, Poly I:C, R848)

Completed
Has Results
  • Allergic Rhinitis
  • +2 more
  • Poly ICLC
  • +5 more
  • Paddington, London, United Kingdom
    Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's H
Nov 3, 2021

Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2021

Recurrent Glioblastoma Trial in Los Angeles (biological, other, drug)

Recruiting
  • Recurrent Glioblastoma
  • Dendritic Cell Tumor Cell Lysate Vaccine
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 29, 2022

Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Diffuse Hemispheric Glioma, H3 G34-Mutant
  • Dendritic Cell Tumor Peptide Vaccine
  • +6 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022

Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +2 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2021

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +5 more
  • Tucson, Arizona
  • +16 more
Oct 19, 2022

Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

Completed
  • Prostate Cancer
  • Intratumoral (IT) Poly ICLC 0.5 mg
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 8, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Orange, California
  • +15 more
Aug 23, 2022

Non-ischemic Dilated Cardiomyopathy Trial in Spain (Control Strategy, Personalized precision ICD implantation Strategy based in

Not yet recruiting
  • Non-ischemic Dilated Cardiomyopathy
  • Control Strategy
  • Personalized precision ICD implantation Strategy based in genetic findings and CMR results
  • Santiago De Compostela, A Coruña, Spain
  • +26 more
Sep 20, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New York (NY-ESO-1 OLP4, NY-ESO-1 OLP4 +

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • NY-ESO-1 OLP4
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)

Recruiting
  • Malignant Pleural Mesothelioma
  • Safety
  • Expansion Cohort
  • New York, New York
    Icahn School of Medicine Mount Sinai
Mar 31, 2022

Advanced Follicular Lymphoma:Translational Study From FIL_FOLL12

Not yet recruiting
  • Follicular Lymphoma
  • EZH2 mutations/CNAs by droplet digital PCR (ddPCR)
  • EZH2-derived gene expression signature by RNA-Seq
  • Alessandria, Italy
  • +25 more
Apr 4, 2023

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

Recruiting
  • Leiomyosarcoma
  • +29 more
  • Definitive Surgical Resection
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L/Montanide ISA 51 VG, Ampligen,

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • OC-L/Montanide ISA 51 VG
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 18, 2021

Individual Variability in (Poly)Phenol Metabolism Trial in Parma (Coffee, Water)

Not yet recruiting
  • Individual Variability in (Poly)Phenol Metabolism
  • Coffee
  • Water
  • Parma, PR, Italy
    University of Parma - Plesso Biotecnologico Integrato
Aug 31, 2023

COVID - 19 Trial in Calgary (Poly-ICLC (Hiltonol®) or Placebo)

Recruiting
  • COVID - 19
  • Poly-ICLC (Hiltonol®) or Placebo
  • Calgary, Alberta, Canada
    Health Research Innovation Centre
Mar 31, 2022